Results 21 to 30 of about 27,928 (247)

A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria [PDF]

open access: yes, 2004
Background<br/><br/> Mutations in the gene coding for the RNA component of telomerase, hTERC, have been found in autosomal dominant dyskeratosis congenita (DC) and aplastic anemia.
Ulku, B.   +35 more
core   +1 more source

Metabolomic studies in hemolytic anemia and aplastic anemia. [PDF]

open access: yes, 2023
Metabolomic studies in hemolytic anemia and aplastic anemia.
Dirce Maria Marchioni   +15 more
core   +1 more source

Eltrombopag in Aplastic Anemia [PDF]

open access: yesSeminars in Hematology, 2015
The treatment of aplastic anemia is currently with immunosuppressive therapy (IST) with anti-thymocyte globulin (ATG) and cyclosporine, to which two thirds of patients respond. However, a significant proportion of these responders relapse and many have persistent cytopenias. The management of these patients is challenging.
Ronan, Desmond   +3 more
openaire   +2 more sources

Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia

open access: yesHaematologica, 2019
Aplastic anemia is a rare but potentially life-threatening disease that may affect older patients. Data regarding the treatment of aplastic anemia in this ageing population remains scarce.
Adrien Contejean   +22 more
doaj   +1 more source

Use of granulocyte colony-stimulating factor for treatment of aplastic anemia [PDF]

open access: yes, 1999
1999-11Over the last ten years, recombinant human granulocyte colony-stimulating factor (rh G-CSF) has been widely used in the treatment of aplastic anemia (AA).
Kojima, Seiji
core   +1 more source

Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study

open access: yesHaematologica, 2009
Background Associations between aplastic anemia and numerous drugs, pesticides and chemicals have been reported. However, at least 50% of the etiology of aplastic anemia remains unexplained.Design and Methods This was a case-control, multicenter ...
Eliane Maluf   +21 more
doaj   +1 more source

Aplastic Anemia in a Developing Country: The Present and the Need [PDF]

open access: yesNational Journal of Laboratory Medicine, 2016
Introduction: Aplastic anemia (AA) a rare, yet a life threatening hematological disorder. Aplastic anemia if untreated results in very high mortality. Early diagnosis of Aplastic anemias is essential for appropriate management of the patient.
Ashwini BR , Seetu Palo, Siddiq M Ahmed
doaj   +1 more source

Successful treatment of severe aplastic anemia with syngeneic stem cell transplantation in the setting of active disseminated mucormycosis

open access: yesMedical Mycology Case Reports, 2019
Severe aplastic anemia (SAA) is a hematological disease resulting in pancytopenia due to bone marrow failure. Treatment consists of immunosppressive therapy, or allo-SCT.
Jean El-Cheikh   +6 more
doaj   +1 more source

Time Series Analysis of Age-Sex Specific Death Rates from Aplastic Anemia and the Trend in Production Amount of Chloramphenicol [PDF]

open access: yes, 1982
1982-03To explore the epidemiological features of aplastic anemia, the mortality statistics (1958-1978) in Japan were examined by age and sex. Mortality trends by age were fitted by the regression curves derived from Akaike Information Criteria Method ...
MIZUNO, SHOICHI   +4 more
core   +1 more source

Latin American Collaborative Research on Aplastic Anemia (LARAA): creating a regional registry [PDF]

open access: yes, 2021
Aplastic anemia (AA) is a rare but serious disease that affects hematopoietic stem cells and is characterized by pancytopenia and a hypocellular bone marrow. It can be a hereditary or acquired condition.
Navarro, Juan Ramón   +16 more
core  

Home - About - Disclaimer - Privacy